Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • Trading Ideas

Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?

By Vandana Singh
May 24, 1:41 PM
Merus announces interim clinical data on petosemtamab and Keytruda (pembrolizumab) for first-line recurrent/metastatic head and neck squamous cell carcinoma. Early results show promising efficacy with a 60% response rate.

MRK

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans’ Health Information Stolen In Data Breach In February

By Vandana Singh
May 24, 12:00 PM
Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.

ABBV

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

Novo Nordisk Releases Data Showing Ozempic For Diabetes Slows Kidney Disease Progression

By Vandana Singh
May 24, 10:37 AM
Novo Nordisk's Ozempic was used on 3,533 patients; results show a 24% reduction in kidney disease progression.

NVO

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

FDA Advisory Panel Supports Approval Of Guardant Health’s Blood Test For Colorectal Cancer Screening

By Vandana Singh
May 24, 9:12 AM
FDA panel recommends approval for Guardant Health's Shield blood test for colorectal cancer screening.

GH

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Top Stories
  • Trading Ideas

What’s Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

By Vandana Singh
May 24, 8:45 AM
Verastem Oncology reports promising initial results from the RAMP 205 trial with an 83% ORR for avutometinib and defactinib in metastatic pancreatic cancer. FDA submission for recurrent KRAS mutant ovarian cancer is underway.

AMGN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Financing
  • General
  • Health Care
  • Movers
  • News
  • Offerings
  • Price Target
  • Top Stories
  • Trading Ideas

Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe

By Vandana Singh
May 23, 2:30 PM
Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's commercialization and cardiovascular pipeline expansion.

CYTK

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal

Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies

By Vandana Singh
May 23, 2:00 PM
U.S. Supreme Court urged by Biden administration to reconsider terrorism funding ruling involving major pharmaceutical and medical equipment companies accused of supporting terrorism in Iraq.

AZN

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Technicals
  • Top Stories
  • Trading Ideas

Pfizer’s Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions

By Surbhi Jain
May 23, 1:36 PM
Pfizer launched a $1.5 billion cost reduction program to enhance operational efficiencies and cut costs amid declining sales. Stock shows bullish momentum.

PFE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Top Stories

Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity

By Vandana Singh
May 23, 12:53 PM
Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will now focus on its PRMT5 program and plans to update on TNG908 and TNG462 later this year.

AZN

Read More
1 minute read
  • Analyst Ratings
  • General
  • Health Care
  • News
  • Price Target
  • Upgrades

GoodRx Strengthens Core Business With New Initiatives, Analyst Upgrades On Potential Opportunities

By Vandana Singh
May 23, 12:38 PM
GoodRx has been upgraded by RBC Capital Markets due to the growth potential from the Integrated Savings Program, direct contracting initiatives, and manufacturing solutions expansion.

GDRX

Posts pagination

Previous 1 … 14 15 16 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service